B. Riley Wealth Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,829
Closed -$261K 1456
2024
Q1
$261K Buy
3,829
+525
+16% +$33.2K 0.01% 1119
2023
Q4
$244K Sell
3,304
-525
-14% -$34.4K 0.01% 1145
2023
Q3
$261K Sell
3,829
-555
-13% -$47.1K 0.01% 1119
2023
Q2
$412K Buy
+4,384
New +$342K 0.01% 957
2022
Q2
Sell
-4,494
Closed -$315K 1281
2022
Q1
$315K Sell
4,494
-294
-6% -$21.5K 0.01% 985
2021
Q4
$373K Sell
4,788
-272
-5% -$24K 0.01% 959
2021
Q3
$504K Sell
5,060
-25
-0.5% -$2.64K 0.02% 776
2021
Q2
$638K Sell
5,085
-1,230
-19% -$147K 0.02% 667
2021
Q1
$833K Buy
6,315
+1,809
+40% +$248K 0.03% 533
2020
Q4
$597K Sell
4,506
-499
-10% -$60.3K 0.03% 476
2020
Q3
$499K Buy
5,005
+946
+23% +$81.7K 0.03% 531
2020
Q2
$353K Buy
+4,059
New +$324K 0.02% 575
2019
Q2
Sell
-4,288
Closed -$372K 801
2019
Q1
$372K Buy
4,288
+343
+9% +$29.2K 0.05% 426
2018
Q4
$249K Buy
+3,945
New +$271K 0.04% 501
2015
Q1
Sell
-404
Closed -$11 1021
2014
Q4
$11 Buy
+404
New +$9.83K ﹤0.01% 2810

Other funds holding EXAS

B. Riley Wealth Advisors's EXAS Position: Q2 2024 in Review

B. Riley Wealth Advisors sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 3,829 shares — an estimated $261K sold.

B. Riley Wealth Advisors first reported a position in EXAS in Q4 2014 and held it in 15 quarters. The position peaked at $833K in Q1 2021. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • B. Riley Wealth Advisors reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 3,829 Exact Sciences shares in Q2 2024, an estimated $261K.
  • B. Riley Wealth Advisors first reported a position in Exact Sciences in Q4 2014 and held it in 15 quarters.
  • B. Riley Wealth Advisors's Exact Sciences position peaked at $833K in Q1 2021.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2024, filed 19 Aug 2024.